outbreak
novel
coronaviru
caus
agent
respiratori
diseas
infect
peopl
sinc
end
kill
caus
worldwid
social
econom
disrupt
current
antivir
drug
proven
efficaci
vaccin
prevent
unfortun
scientif
commun
littl
knowledg
molecular
detail
infect
illumin
clone
tag
express
viral
protein
human
cell
identifi
human
protein
physic
associ
use
affinitypurif
mass
spectrometri
apm
identifi
high
confid
proteinprotein
interact
ppi
among
identifi
druggabl
human
protein
host
factor
target
exist
fdaapprov
drug
drug
clinic
trial
andor
preclin
compound
current
evalu
efficaci
live
infect
assay
identif
host
depend
factor
mediat
viru
infect
may
provid
key
insight
effect
molecular
target
develop
broadli
act
antivir
therapeut
deadli
coronaviru
strain
polymeras
rdrp
inhibitor
remdesivir
recent
data
suggest
new
nucleotid
analog
may
effect
infect
laboratori
anim
clinic
trial
sever
vaccin
candid
also
underway
well
trial
repurpos
hostdirect
compound
inhibit
human
proteas
believ
great
potenti
systemat
explor
host
depend
viru
identifi
host
protein
alreadi
target
exist
drug
therapi
target
hostviru
interfac
mutat
resist
arguabl
less
like
could
potenti
present
durabl
broadspectrum
treatment
modal
unfortun
minim
knowledg
molecular
detail
infect
preclud
comprehens
evalu
small
molecul
candid
hostdirect
therapi
sought
address
knowledg
gap
systemat
map
interact
landscap
protein
human
protein
sequenc
analysi
isol
suggest
genom
encod
mani
open
read
frame
orf
encod
polyprotein
autoproteolyt
process
nonstructur
protein
form
replicas
transcriptas
complex
rtc
rtc
consist
multipl
enzym
includ
papainlik
proteas
main
proteas
primas
complex
primari
rnadepend
rna
polymeras
helicasetriphosphatas
exoribonucleas
endonucleas
omethyltransferas
end
viral
genom
mani
orf
express
nine
predict
subgenom
rna
includ
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
nine
put
accessori
factor
fig
genet
composit
genom
similar
sarscov
encod
predict
nsp
four
typic
coronaviru
structur
protein
howev
differ
complement
open
read
frame
possess
limit
detect
protein
homolog
sarscov
intact
sarscov
encod
fig
matur
nsp
predict
protein
express
orf
protein
plu
one
mutant
codon
optim
clone
mammalian
express
vector
tag
fuse
either
cterminu
protein
express
plasmid
transfect
human
cell
incub
hour
lysi
mild
deterg
buffer
viral
protein
affin
purifi
use
magstrep
bead
bead
wash
onbead
digest
perform
overnight
peptid
desalt
analyz
protein
mass
spectrometri
high
confid
interactor
identifi
use
saintexpress
mist
algorithm
verifi
viral
protein
express
perform
antistrep
western
blot
input
cell
lysat
except
observ
band
consist
predict
protein
size
construct
despit
lack
detect
via
western
blot
abl
detect
express
viral
peptid
proteom
analysi
fourth
construct
confirm
western
blot
small
peptid
predict
molecular
mass
kda
includ
tag
appar
mass
approxim
kda
fig
limit
homolog
sarscov
restrict
express
measur
western
blot
apm
may
indic
either
bonafid
protein
code
gene
requir
coexpress
protein
robust
express
ultim
proceed
analysi
protein
interact
data
bait
exclud
high
prey
detect
background
fig
affin
purificationmass
spectrometri
analysi
identifi
protein
interact
protein
human
protein
extend
data
fig
supplementari
tabl
also
see
fig
studi
interact
human
protein
regard
cell
biolog
anatom
express
pattern
express
chang
infect
relat
map
pathogen
interact
protein
fig
viral
protein
perform
gene
ontolog
enrich
analysi
fig
extend
data
fig
identifi
major
cell
biolog
process
interact
protein
includ
lipoprotein
metabol
nuclear
transport
biogenesi
ribonucleoprotein
discov
potenti
bind
interfac
perform
enrich
domain
famili
within
interact
protein
viral
bait
extend
data
fig
exampl
note
enrich
dna
polymeras
domain
interactor
enrich
bromodomain
extratermin
domain
bet
famili
interactor
e
see
also
fig
line
latter
interactor
e
also
enrich
gene
annot
bind
acetyl
histon
fig
cell
use
apm
experi
kidney
cell
permiss
infect
repres
primari
physiolog
site
infect
therefor
ask
whether
host
protein
bound
might
specif
relev
viru
typic
environ
lung
tissu
test
interact
human
protein
preferenti
highli
express
protein
level
human
tissu
identifi
lung
tissu
highest
express
prey
protein
rel
averag
proteom
fig
accord
compar
overal
refseq
gene
express
lung
tpm
interact
protein
highli
express
tpm
ttest
extend
data
fig
also
specif
enrich
lung
express
rel
tissu
extend
data
fig
data
support
hypothesi
preferenti
hijack
protein
avail
lung
tissu
degre
tissu
specif
express
may
facilit
drug
target
host
factor
fewer
system
sideeffect
observ
particularli
compel
given
deriv
cell
lung
deriv
studi
relev
map
analyz
recent
report
protein
abund
chang
infect
calcul
possibl
correl
chang
abund
viral
protein
human
interact
partner
across
timepoint
report
interact
pair
tend
stronger
correl
chang
pair
viralhuman
protein
fig
ks
test
argu
apm
deriv
interact
high
relev
target
tissu
infect
context
compar
interact
map
deriv
pathogen
fig
identifi
west
nile
viru
wnv
mycobacterium
tuberculosi
mtb
similar
host
protein
interact
partner
associ
mtb
particularli
interest
consid
also
infect
lung
tissu
final
studi
evolutionari
properti
host
protein
success
viru
spread
divers
popul
theori
could
facilit
relianc
conserv
host
molecular
compon
therefor
analyz
conserv
human
protein
identifi
interactom
rel
control
sampl
gene
interact
human
protein
deplet
missens
prematur
stop
mutat
gnomad
indic
reduc
genet
variat
human
popul
extend
data
fig
studi
highlight
interact
protein
human
protein
rang
function
includ
dna
replic
epigenet
gene
express
regul
e
vesicl
traffick
e
lipid
modif
spike
rna
process
regul
n
ubiquitin
ligas
signal
n
nuclear
transport
machineri
cytoskeleton
mitochondria
extracellular
matrix
fig
promin
number
interact
relat
lipid
modif
vesicl
traffick
interestingli
spike
protein
interact
acyltransferas
complex
like
mediat
palmitoyl
cytosol
tail
see
also
appendix
palmitoyl
report
facilit
membran
fusion
sarscov
spike
suggest
potenti
target
therapeut
inhibit
interestingli
also
publish
role
allow
anthrax
toxin
enter
cell
suggest
inhibit
enzym
could
broad
util
host
interact
signal
recognit
particl
endoplasm
reticulum
qualiti
control
er
structur
morpholog
protein
golgin
may
facilit
dramat
reconfigur
ergolgi
traffick
coronaviru
infect
interact
peripher
compart
vacuolar
atpas
rab
e
hop
may
also
modifi
endomembran
compart
favor
coronaviru
replic
identifi
proteinprotein
interact
main
proteas
use
wildtyp
catalyt
dead
construct
wildtyp
identifi
one
highconfid
interact
epigenet
regul
histon
deacetylas
predict
cleavag
site
hdac
domain
nuclear
local
sequenc
suggest
may
inhibit
transport
nucleu
extend
data
fig
potenti
impact
publish
function
mediat
inflamm
interferon
respons
also
identifi
interact
trna
methyltransferas
respons
synthesi
dimethylguanosin
base
modif
nuclear
mitochondri
trna
predict
also
cleav
remov
zinc
finger
nuclear
local
signal
like
result
exclus
mitochondri
local
extend
data
fig
identifi
number
cellular
protein
implic
innat
immun
signal
target
sever
viral
protein
interestingli
found
interact
two
key
player
ifn
signal
pathway
includ
tankbind
kinas
tankbind
kinas
protein
sintbad
act
critic
adaptor
protein
ikki
therefor
mediat
induct
irfdepend
transcript
interact
multipl
protein
tle
famili
known
modul
inflammatori
respons
ubiquitin
ligas
target
protein
promot
activ
therefor
increas
type
interferon
product
two
ubiquitin
ligas
regul
antivir
innat
immun
signal
usurp
respect
protein
found
interact
multipl
protein
modul
ikb
kinas
nfkb
signal
pathway
includ
also
found
interact
mitochondri
import
receptor
act
essenti
adaptor
link
mav
result
activ
n
target
stress
granul
protein
essenti
antivir
protein
known
induc
innat
immun
respons
multipl
mechan
common
among
coronavirida
manipul
stress
granul
sg
relat
rna
biolog
possibl
lead
suppress
stress
granul
host
translat
shutoff
function
seem
benefit
viral
replic
stress
granul
inhibitori
replic
merscov
virus
nucleocapsid
n
interactom
includ
mani
host
mrna
bind
protein
includ
sg
relat
factor
mtor
translat
repressor
protein
kinas
fig
sg
induc
protein
kinas
r
pkr
mediat
phosphoryl
upon
viral
dsrna
recognit
promot
aggreg
via
inhibitor
zotatafin
reduc
sg
disassembl
silmitasertib
inhibit
warrant
investig
treatment
mtor
inhibitor
rapamycin
disrupt
bind
shown
reduc
mer
infect
vitro
anoth
drug
could
test
repurpos
sarscov
shown
play
role
antagon
host
interferon
signal
identifi
novel
highconfid
interact
interferoninduc
mrna
nuclear
export
complex
hijack
degrad
multipl
virus
includ
vsv
influenzaa
kshv
polio
restrict
factor
influenzaa
infect
xray
structur
vsv
protein
complex
reveal
key
bind
interact
includ
buri
methionin
residu
mprotein
pack
hydrophob
pocket
well
neighbor
acid
residu
interact
basic
patch
complex
fig
bind
featur
also
present
conserv
motif
ctermin
region
fig
extend
data
fig
provid
structur
hypothesi
observ
interact
moreov
peptid
contain
bind
region
vsv
protein
previous
shown
outcompet
rna
bind
suggest
role
interf
mrna
export
observ
suggest
viral
strategi
target
rna
nuclear
export
activ
potenti
reveal
mode
interferon
antagon
virus
commonli
hijack
ubiquitin
pathway
replic
pathogenesi
novel
interact
multipl
member
cullin
ring
ligas
complex
fig
specif
complex
substrat
adapt
target
substrat
expos
ntermin
glycin
degrad
highest
score
protein
interactom
suggest
direct
interact
may
bind
complex
hijack
ubiquitin
degrad
restrict
factor
ubiquitin
transfer
substrat
requir
neddyl
via
enzym
nae
druggabl
target
inhibit
small
molecul
pevonedistat
fig
surprisingli
find
transmembran
protein
e
bind
bromodomaincontain
protein
fig
extend
data
fig
potenti
disrupt
brdhiston
bind
mimick
histon
structur
member
bromodomain
extratermin
bet
domain
famili
whose
member
bind
acetyl
histon
regul
gene
transcript
nterminu
histon
share
local
sequenc
similar
alphahelix
approxim
residu
transmembran
segment
protein
e
fig
moreov
match
region
histon
span
acetyl
lysin
residu
shown
bind
analysi
may
suggest
protein
e
mimic
histon
disrupt
interact
thu
induc
chang
host
protein
express
benefici
viru
comprehens
overview
virushost
interact
detect
see
supplement
discuss
identifi
small
molecul
target
human
protein
interactom
sought
ligand
known
interact
human
protein
often
directli
also
pathway
complex
draw
chemoinformat
databas
analys
method
molecul
priorit
statist
signific
interact
human
viral
protein
statu
approv
drug
investig
new
drug
ind
clinic
tabl
b
preclin
candid
appar
select
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
avail
purchas
avail
note
see
supplement
tabl
chemoinformat
search
yield
approv
drug
four
investig
new
drug
clinic
preclin
candid
tabl
specialist
knowledg
reveal
approv
drug
investig
new
drug
clinic
preclin
candid
tabl
human
target
interact
viral
bait
protein
high
signific
drugsindspreclin
molecul
modul
fig
reduc
protein
interact
score
threshold
slightli
find
addit
four
human
target
reveal
total
human
target
supplementari
tabl
drughuman
protein
associ
may
overlaid
top
protein
interact
network
highlight
potenti
druggabl
host
interact
fig
sever
mechanist
interest
potenti
diseaserelev
drugtarget
interact
reveal
chemoinformat
network
fig
among
wellknown
chemic
probe
bafilomycin
potent
inhibitor
subunit
interact
bafilomycin
inhibit
cotransport
act
prevent
acidif
lysosom
inhibit
autophagi
endosom
traffick
pathway
may
impact
viral
lifecycl
similarli
drug
exist
target
sever
wellknown
epigenet
regul
promin
among
human
interactor
includ
interact
viral
protein
e
respect
fig
approv
drug
valproic
acid
anticonvuls
preclin
candid
apicidin
inhibit
affin
nm
respect
clinic
compound
act
affin
nm
nm
respect
sever
preclin
compound
also
target
bromodomaincontain
protein
tabl
b
final
exampl
intrigu
observ
protein
interact
sigma
receptor
thought
regul
er
stress
respons
similarli
receptor
interact
vial
protein
promiscu
receptor
interact
mani
nonpolar
cation
drug
priorit
sever
drug
base
potenc
potenti
diseas
relev
includ
antipsychot
haloperidol
bind
low
nm
rang
receptor
chloroquin
current
clinic
trial
midnm
activ
vs
receptor
low
activ
receptor
mani
patient
alreadi
treat
drug
offtarget
impact
sigma
receptor
associ
clinic
outcom
accompani
treatment
drug
may
merit
investig
point
return
final
addit
druggabl
host
factor
highlight
interactom
reveal
mani
tradit
undrugg
target
among
instanc
compon
centriol
interact
viral
intriguingli
recent
patent
disclosur
reveal
natur
product
directli
specif
target
natur
product
would
like
harder
sourc
molecul
focus
may
well
merit
investig
similarli
undrugg
target
may
reveal
compound
could
use
perturb
viralhuman
interact
network
act
lead
therapeut
beyond
direct
interact
sever
drugpathway
interact
seem
noteworthi
human
purin
biosynthesi
enzym
dehydrogenas
interact
viral
protein
sever
chemic
divers
compound
inhibit
includ
clinic
approv
mycophenol
acid
nm
approv
antivir
drug
ribavirin
nm
investig
new
drug
merimepodib
nm
tabl
intriguingli
preclin
molecul
sanglifehrin
tabl
known
act
molecular
glue
link
impdh
cyclophilin
fig
implic
viral
capsid
packag
even
though
human
prey
viralhuman
protein
interactom
similarli
direct
viralhuman
interact
protein
regul
pathway
interact
viral
n
protein
led
us
inhibitor
even
though
kinas
found
directli
interact
viral
protein
fig
sapanisertib
rapamycin
low
nm
inhibitor
metformin
indirect
modul
protein
complex
use
affin
purificationmass
spectrometri
identifi
highconfid
ppi
find
viral
protein
connect
wide
array
biolog
process
includ
protein
traffick
translat
transcript
ubiquitin
regul
use
combin
systemat
chemoinformat
drug
search
pathway
centric
analysi
uncov
close
differ
drug
compound
includ
fda
approv
drug
compound
clinic
trial
well
preclin
compound
target
part
result
network
current
test
compound
antivir
activ
encourag
other
well
extract
insight
map
could
therapeut
valu
gener
proteomicchemoinformat
analysi
identifi
drug
clinic
molecul
might
perturb
viralhuman
interactom
give
potenti
therapeut
perturb
mechanist
context
among
may
infect
relev
inhibit
lysosom
acidif
traffick
bafilomycin
via
inhibit
vatpas
modul
er
stress
protein
unfold
respons
pathway
target
receptor
drug
like
haloperidol
fig
tabl
b
inde
sever
human
protein
interactom
target
drug
emerg
phenotyp
candid
therapeut
treat
chloroquin
pretend
identifi
molecular
basi
chloroquin
put
activ
note
drug
target
receptor
midnm
low
concentr
respect
similarli
antibiot
like
azithromycin
also
moot
treatment
remain
demonstr
note
azithromycin
offtarget
activ
human
mitochondri
ribosom
compon
interact
protein
antibiot
also
offtarget
effect
mitochondri
ribosom
chloramphenicol
tigecyclin
linezolid
may
also
merit
studi
efficaci
inde
logic
may
extend
mani
patient
drug
identifi
treat
preexist
condit
may
use
correl
clinic
outcom
take
drug
crossreferenc
network
describ
sens
alreadi
occur
phenomenolog
lead
concern
ace
inhibitor
captopril
enalapril
nsaid
studi
provid
systemat
schema
clinicaldrug
associ
go
forward
give
mechanist
context
allow
investig
seek
directli
systemat
valid
use
geneticbas
approach
key
determin
function
relev
interact
human
protein
use
viru
fight
infect
inform
would
inform
futur
pharmacolog
studi
import
note
pharmacolog
intervent
agent
identifi
studi
could
either
detriment
benefici
infect
instanc
inhibitor
may
compound
potenti
action
proteas
hydrolyz
human
protein
futur
work
involv
gener
proteinprotein
interact
map
differ
human
cell
type
well
bat
cell
studi
relat
coronavirus
includ
sarscov
merscov
less
virul
data
allow
valuabl
crossspeci
viral
evolut
studi
target
biochem
structur
studi
also
crucial
deeper
understand
viralhost
complex
inform
target
drug
design
along
previous
util
global
affin
purificationmass
spectrometri
apm
analysi
map
hostpathogen
interfac
number
human
pathogen
includ
ebola
dengu
zika
herpesviru
hepat
c
tuberculosi
chlamydia
enterovirus
hiv
hpv
west
nile
fever
excitingli
uncov
share
uniqu
mechan
pathogen
coopt
host
machineri
cours
infect
although
hostdirect
therapi
often
explor
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
combat
pathogen
infect
would
interest
use
inform
identifi
host
factor
could
serv
target
would
harbor
panpathogen
activ
next
viru
undergo
zoonosi
treatment
option
avail
supplementari
inform
avail
paper
correspond
request
materi
address
nevankrogan
ucsfedu
reprint
permiss
inform
avail
wwwnaturecomreprint
author
file
patent
protect
host
interact
use
predict
drug
treat
ensur
inform
freeli
avail
acceler
discoveri
treatment
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
similar
sarscov
homolog
infer
function
base
sarscov
homolog
c
immunoblot
detect
tag
demonstr
express
bait
input
sampl
indic
red
arrowhead
experiment
workflow
express
tag
fusion
protein
biolog
triplic
cell
follow
affin
purificationmass
spectrometri
ppi
score
identifi
high
confid
proteinprotein
interact
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
transmembran
segment
iii
model
e
might
mimic
nativ
interact
partner
histon
target
pharmacolog
chemoinformat
expert
analysi
identifi
fda
approv
drug
green
clinic
candid
yellow
preclin
candid
purpl
experiment
activ
host
protein
process
repres
chemic
shown
b
inosin
monophosph
dehydrogenas
regul
de
novo
nucleic
acid
biosynthesi
target
prolif
diseas
includ
cancer
autoimmun
disord
instanc
approv
drug
mycophenol
acid
broad
spectrum
antivir
ribavirin
ribavirin
activ
sar
vitro
low
toler
someth
might
address
select
merimepodib
phase
ii
clinic
trial
c
mammalian
target
rapamycin
mtor
pathway
master
regul
cell
prolifer
autophagi
virus
includ
influenza
known
modul
sever
protein
interact
bait
includ
compon
respiratori
complex
leucin
import
b
n
shown
addit
rapamycin
mtor
pathway
indirectli
modul
metformin
wide
prescrib
diabet
drug
sapanisertib
drug
clinic
trial
solid
tumor
transfect
affin
purif
ten
million
cell
plate
per
dish
transfect
individu
streptag
express
construct
hour
total
plasmid
normal
empti
vector
complex
polyjet
transfect
reagent
signagen
laboratori
ratio
plasmid
transfect
reagent
base
manufactur
recommend
hour
cell
dissoci
room
temperatur
use
ml
dulbecco
phosphat
buffer
salin
without
calcium
magnesium
dpb
supplement
mm
edta
least
minut
subsequ
wash
ml
dpb
step
follow
centrifug
xg
minut
cell
pellet
frozen
dri
ice
store
least
three
biolog
replic
independ
prepar
affin
purif
affin
purif
frozen
cell
pellet
thaw
ice
minut
suspend
ml
lysi
buffer
ip
buffer
mm
trishcl
ph
mm
nacl
mm
edta
supplement
nonidet
p
substitut
fluka
analyt
complet
mini
edtafre
proteas
phosstop
phosphatas
inhibitor
cocktail
roch
sampl
frozen
dri
ice
minut
partial
thaw
incub
tube
rotat
minut
centrifug
xg
minut
pellet
debri
reserv
lysat
sampl
array
deepwel
plate
affin
purif
kingfish
flex
purif
system
thermo
scientif
follow
magstrep
bead
iba
lifesci
equilibr
twice
ml
wash
buffer
ip
buffer
supplement
incub
ml
lysat
hour
bead
wash
three
time
ml
wash
buffer
ml
ip
buffer
directli
digest
beadbound
protein
well
elut
protein
biotin
bead
manual
suspend
ip
buffer
divid
half
transfer
denaturationreduct
buffer
urea
mm
trishcl
ph
mm
dtt
buffer
bxt
iba
lifesci
dispens
singl
kf
microtit
plate
respect
purifi
protein
first
elut
room
temperatur
minut
constant
shake
rpm
thermomix
c
incub
remov
eluat
onbead
digest
proceed
streptag
protein
express
lysat
enrich
eluat
assess
western
blot
silver
stain
respect
kingfish
flex
purif
system
place
cold
room
allow
equilibr
overnight
use
autom
protocol
step
perform
use
slow
mix
speed
follow
mix
time
second
equilibrationwash
step
hour
bind
minut
final
bead
releas
three
second
bead
collect
time
use
step
onbead
digest
beadbound
protein
denatur
reduc
minut
bring
room
temperatur
alkyl
dark
mm
iodoacetamid
minut
quench
mm
dtt
minut
protein
incub
initi
hour
trypsin
promega
anoth
hour
addit
trypsin
offset
evapor
mm
trishcl
ph
ad
trypsin
digest
step
perform
constant
shake
rpm
thermomix
c
incub
result
peptid
combin
mm
trishcl
ph
use
rins
bead
acidifi
trifluoroacet
acid
final
ph
acidifi
peptid
desalt
ms
analysi
use
biopuresp
mini
plate
proto
nest
group
inc
accord
standard
protocol
mass
spectrometri
data
acquisit
analysi
sampl
resuspend
formic
acid
acetonitril
solut
separ
reversedphas
gradient
nanoflow
column
dr
maisch
sampl
analyz
two
differ
mass
spectromet
first
min
acquisit
peptid
directli
inject
via
easynlc
thermo
qexact
plu
mass
spectromet
thermo
spectra
collect
orbitrap
acquisit
qcloud
use
control
instrument
longitudin
perform
project
proteom
data
search
human
proteom
uniprot
review
sequenc
download
februari
egfp
sequenc
protein
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sequenc
use
default
set
maxquant
detect
peptid
protein
filter
fals
discoveri
rate
maxquant
identifi
protein
subject
proteinprotein
interact
score
saintexpress
mist
appli
two
step
filter
strategi
determin
final
list
report
interactor
reli
two
differ
score
stringenc
cutoff
first
step
chose
protein
interact
possess
mist
score
saintexpress
bfdr
averag
spectral
count
protein
fulfil
criteria
extract
inform
stabl
protein
complex
particip
corum
databas
known
protein
complex
second
step
relax
stringenc
recov
addit
interactor
form
complex
interactor
determin
filter
step
fulfil
follow
criteria
mist
score
saintexpress
bfdr
averag
spectral
count
protein
fulfil
filter
criteria
either
step
step
consid
hcppi
visual
cytoscap
use
filter
criteria
nearli
bait
recov
number
hcppi
close
align
previou
dataset
report
averag
ppi
per
bait
howev
subset
bait
observ
much
higher
number
ppi
pass
filter
criteria
four
bait
mist
score
instead
perform
use
larger
inhous
databas
bait
prepar
process
analog
manner
dataset
done
provid
comprehens
collect
bait
comparison
minim
classif
nonspecif
bind
background
protein
hcppi
mass
spectrometri
raw
data
search
result
file
deposit
proteomexchang
consortium
via
pride
partner
repositori
dataset
identifi
ppi
network
also
upload
ndex
gene
ontolog
overrepresent
analysi
target
bait
test
enrich
gene
ontolog
go
biolog
process
term
overrepresent
analysi
ora
perform
use
enrich
function
clusterprofil
packag
r
default
paramet
gene
ontolog
term
obtain
categori
molecular
signatur
databas
signific
go
term
fdr
identifi
refin
select
nonredund
term
order
select
nonredund
gene
set
first
construct
go
term
tree
base
distanc
similar
coeffici
share
gene
signific
term
go
term
tree
cut
specif
level
identifi
cluster
nonredund
gene
set
bait
multipl
signific
term
belong
cluster
select
broadest
term
ie
largest
gene
set
size
viru
interactom
similar
analysi
interactom
similar
assess
compar
number
share
human
interact
protein
pathogen
pair
use
hypergeometr
test
calcul
signific
background
gene
set
test
consist
uniqu
protein
detect
mass
spectrometri
across
pathogen
gene
peptid
model
propos
interact
complex
model
pyrosetta
releas
use
crystal
structur
vesicular
stomat
viru
matrix
protein
bound
templat
pdb
download
pdbredo
server
protein
chain
c
truncat
residu
restrict
model
put
interact
motif
protein
residu
sequenc
demdth
residu
mutat
sequenc
qpmeid
use
mutateresidu
function
modul
pyrosettatoolbox
without
repack
initi
step
six
residu
mutat
full
model
relax
low
energi
conform
use
fastrelax
protocol
modul
pyrosettarosettaprotocolsrelax
fastrelax
run
constraint
start
coordin
score
score
function
result
model
inspect
larg
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
energet
penalti
associ
model
peptid
residu
residu
interact
peptid
found
none
model
visual
pymol
pymol
molecular
graphic
system
version
llc
homolog
model
gener
homolog
model
built
swissmodel
model
use
homolog
templat
domain
pdb
databas
pdb
code
model
two
structur
domain
leucin
rich
repeat
lrr
armadillo
repeat
arm
n
cterminu
respect
linker
domain
model
due
high
flexibl
residu
residu
put
protein
interact
surfac
model
base
contigu
surfac
expos
residu
conserv
orthologu
c
elegan
h
sapien
locat
typic
substrat
bind
site
homolog
structur
lrr
arm
domain
cocomplex
order
align
protein
e
histon
structur
protein
e
sarscov
homolog
pdb
id
compar
human
nucleosom
structur
pdb
id
protein
e
structur
align
histon
subunit
use
pymol
align
function
http
pymolwikiorgindexphpalign
align
perform
sequenc
align
follow
structur
superposit
carri
zero
cycl
refin
order
reject
structur
outlier
found
fit
best
superposit
obtain
residu
protein
e
residu
rmsd
report
figur
identifi
drug
reagent
modul
host
factor
interact
mist
use
two
approach
chemoinformat
analysi
opensourc
chemic
databas
targetand
pathwayspecif
literatur
search
draw
specialist
knowledg
within
group
chemoinformat
retriev
molecul
iupharbp
guid
pharmacolog
interact
human
prey
protein
approv
clinic
trial
found
molecul
approv
clinic
trial
databas
supplementari
tabl
approach
molecul
priorit
fda
approv
statu
activ
target
interest
better
commerci
avail
draw
zinc
databas
fda
approv
molecul
priorit
except
clinic
candid
preclin
research
molecul
substanti
better
select
potenc
ontarget
case
consid
molecul
indirect
mechan
action
gener
pathway
interest
base
sole
literatur
evid
eg
captopril
modul
indirectli
via
direct
interact
angiotensin
convert
enzym
ace
final
predict
addit
molecul
approv
clinic
trial
protein
mist
score
viral
bait
supplement
tabl
complet
method
found
molecul
deriv
expert
analysi
human
protein
interactor
reagent
drug
modul
readili
avail
chemoinformaticallysearch
literatur
open
read
frame
tigecyclin
linezolid
mycophenol
acid
sanglifehrin
